五洲医疗（301234）10月13日主力资金净卖出2094.69万元

Core Viewpoint - Wuzhou Medical (301234) experienced a stock price increase of 6.13% on October 13, 2025, closing at 46.22 yuan, with a trading volume of 32,400 hands and a total transaction amount of 147 million yuan [1] Group 1: Stock Performance and Trading Data - On October 13, 2025, the main funds had a net outflow of 20.95 million yuan, accounting for 14.25% of the total transaction amount, while retail investors had a net inflow of 17.15 million yuan, representing 11.67% of the total [1] - Over the past five days, the stock's closing prices and changes were as follows: - October 13: 46.22 yuan (+6.13%) - October 10: 43.55 yuan (-2.73%) - October 9: 44.77 yuan (+2.92%) - September 30: 43.50 yuan (+0.35%) - September 29: 43.35 yuan (+3.17%) [2] Group 2: Financing and Margin Trading - On October 13, 2025, the financing balance was 95.73 million yuan, with a net financing purchase of 5.77 million yuan [3] - The financing data for the past five days showed fluctuations in financing balance and net purchases, with the highest net purchase recorded on October 13 [3] Group 3: Company Financials and Industry Comparison - Wuzhou Medical reported a main revenue of 217 million yuan for the first half of 2025, a year-on-year increase of 2.26%, but a net profit of 10.52 million yuan, a decrease of 51.69% [5] - Key financial metrics for Wuzhou Medical compared to the medical device industry average include: - Total Market Value: 3.159 billion yuan vs. 11.912 billion yuan - Net Assets: 753 million yuan vs. 3.889 billion yuan - Net Profit: 10.5151 million yuan vs. 149 million yuan - PE Ratio: 150.19 vs. 66.32 - Gross Margin: 14.33% vs. 51.85% [5]